Latest filingSep 02, 2026Most recent Form 4
TENX
TENAX THERAPEUTICS, INC.
NasdaqHealthcarePharmaceutical Preparations
Insider activity for last month from 08/03 to 09/03. Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.
Total buying$319M6 buys
Total selling$00 sells
Net open-market+$319M2 insiders
Open-market mix
Buy vs sell distribution by transaction countInsider activity report
Monthly open-market purchase and sale counts Buys Sells
Transaction codes
By Form 4 transaction code in selected period6transactions
- P · Open-market buys · dominant6 · 100%
Activity by reported role
A joint filing can contribute to multiple roles6transactions
- 10% owner · dominant6 · 100%
Distinct insiders active
Reporting-owner CIKs by month · peak Aug 2026 (2)Aug 2026Sep 2026
Reported Holdings After
Separated by insider, security, and ownership typeSchneeberger DanielCommon Stock · Indirect · See Footnote
5,624,151Sep 02, 2026
ADAR1 Capital Management, LLCCommon Stock · Indirect · See Footnote
5,624,151Sep 02, 2026
These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.
Filing activity heatmap
Each cell is one day · intensity = transactions · buys green, sells redAug 03 → Sep 03
LessMore
Top insiders
By absolute net value across the selected period- AL+$3.2M
Filing detail checks
Secondary metrics for the selected periodFiling-only signals
Deterministic matches in the selected period
TENX transaction history
Filters apply within this company and selected period by default| Ticker | Insider | Role | Type | Shares | Value | Code | Signals | 90d return | Filed | Trans date |
|---|---|---|---|---|---|---|---|---|---|---|
| TENX | ADAR1 Capital Management, LLC | 10% | buy | 187k | $33.7M | P | — | 0.0% | 09/02 | 09/02 |
| TENX | ADAR1 Capital Management, LLC | 10% | buy | 179k | $32.1M | P | — | 0.0% | 09/02 | 09/01 |
| TENX | ADAR1 Capital Management, LLC | 10% | buy | 403k | $72.2M | P | — | 0.0% | 09/02 | 08/31 |
| TENX | ADAR1 Capital Management, LLC | 10% | buy | 107k | $18.8M | P | +20.0% | 08/24 | 08/24 | |
| TENX | ADAR1 Capital Management, LLC | 10% | buy | 716k | $126M | P | +20.0% | 08/24 | 08/21 | |
| TENX | ADAR1 Capital Management, LLC | 10% | buy | 202k | $35.9M | P | +20.0% | 08/24 | 08/20 |
TENAX THERAPEUTICS, INC. Insider Activity FAQ
SEC Form 4 contextWho recently reported transactions at TENAX THERAPEUTICS, INC.?
ADAR1 Capital Management, LLC, Schneeberger Daniel.
When was the latest reported open-market purchase?
ADAR1 Capital Management, LLC reported a buy on Sep 02, 2026 valued at $33.7M. Read the SEC filing.
When was the latest reported open-market sale?
No code-S sale is available for this period.
What is the recent purchase and sale balance?
Net open-market buying in the selected period was $3,195,897.26. This describes filed transactions, not a bullish rating.
Where can I see the original SEC filing?
Every transaction row and latest-activity fact links to its original SEC filing.
What do these Form 4 transaction codes mean?
P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.